Pharmacy |
| ||
|
Catapres TTS 3 Generic Clonidine |
|
| ||
Home » Prescription Drugs 4 » Catapres TTS 3 Generic Clonidine Indications:CATAPRES-TTS is indicated for the treatment of mild to moderate hypertension. It can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.Dosage and Administration:CATAPRES-TTS dosage should be titrated according to individual patient's therapeutic requirements. Commence with one CATAPRES-TTS-1 applied weekly to a freshly cleaned hairless area of the upper outer arm or chest. A new site should be used each week when applying new patches. If after two to four weeks the desired reduction in blood pressure is not achieved increase the weekly dosage by changing to CATAPRES-TTS-2. If this dosage is still not satisfactory after 2-4 weeks therapy then increase the weekly dosage by changing to CATAPRES-TTS-3.Most patients with mild to moderate hypertension will be controlled on one CATAPRES-TTS-3 or less. In more resistant cases where blood pressure is not satisfactorily controlled on one CATAPRES-TTS-3 it is recommended that a diuretic and/or other antihypertensive agents be added to enhance the hypotensive effect. In this way the dose of each individual drug may be reduced and side effects minimised. Higher doses of up to two CATAPRES-TTS-3 a week have been utilised.When substituting CATAPRES-TTS in patients on prior oral antihypertensive therapy including oral CATAPRES physicians should be aware that the antihypertensive effect of CATAPRES-TTS might not commence until 2-3 days after initial application. Therefore gradual reduction of prior drug dosage over 5-6 days is advised.Instructions on correct application of CATAPRES-TTS are provided on a separate patient leaflet. Buy Catapres TTS 3 Generic Clonidine and other Prescription Drugs 4 products online at Medstore. 5464
About Catapres TTS 3 Generic Clonidine: Product Type: Prescription Drugs 4 Catapres TTS-3 ( Generic Clonidine ) Catapres TTS-3 (Generic Clonidine) Generic Clonidine 7.5mg/10.5cm 4 Pads Generic Clonidine Catapres TTS-3
View more Prescription Drugs 4 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
